Clinical Manifestations and Prognosis of Anti-Signal-Recognition-Particle Myositis

Overview

Journal J Clin Neurol

Specialty Neurology

Date 2024 Jul 2

PMID 38951980

Authors

Seol-Hee Baek

Kyomin Choi

Hyunjin Ju

Jeeyoung Oh

Byoung Joon Kim

Byung-Jo Kim

Affiliations

Soon will be listed here.

Citing Articles

Profiling of Anti-Signal-Recognition Particle Antibodies and Clinical Characteristics in South Korean Patients With Immune-Mediated Necrotizing Myopathy.

Kim S, Choi Y, Oh E, Nishino I, Suzuki S, Suh B J Clin Neurol. 2025; 21(1):31-39.

PMID: 39778565 PMC: 11711272. DOI: 10.3988/jcn.2024.0333.

References

Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J . Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis. 2015; 10:61. PMC: 4440264. DOI: 10.1186/s13023-015-0277-y. View

Miller T, Al-Lozi M, Lopate G, Pestronk A . Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry. 2002; 73(4):420-8. PMC: 1738058. DOI: 10.1136/jnnp.73.4.420. View

Benveniste O, Drouot L, Jouen F, Charuel J, Bloch-Queyrat C, Behin A . Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011; 63(7):1961-71. DOI: 10.1002/art.30344. View

Hengstman G, ter Laak H, Vree Egberts W, Lundberg I, Moutsopoulos H, Vencovsky J . Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006; 65(12):1635-8. PMC: 1798474. DOI: 10.1136/ard.2006.052191. View

Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F . Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA Neurol. 2018; 75(12):1528-1537. PMC: 6583199. DOI: 10.1001/jamaneurol.2018.2598. View

Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K . Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry. 2016; 87(10):1038-44. DOI: 10.1136/jnnp-2016-313166. View

Van Horebeek N, Vulsteke J, Bossuyt X, Claeys K, Dillaerts D, Poesen K . Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review. Semin Arthritis Rheum. 2021; 51(2):486-494. DOI: 10.1016/j.semarthrit.2021.03.012. View

Oh E, Lee S, Lee H, Cha Y, Kim S, Lee H . Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy. J Clin Neurol. 2023; 19(5):460-468. PMC: 10471552. DOI: 10.3988/jcn.2022.0374. View

Hoogendijk J, Amato A, Lecky B, Choy E, Lundberg I, Rose M . 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004; 14(5):337-45. DOI: 10.1016/j.nmd.2004.02.006. View

10.

Huang H, Lin W, Tsai W, Weng C, Weng M, Wu C . Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies. J Clin Med. 2022; 11(23). PMC: 9739947. DOI: 10.3390/jcm11236972. View